DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Botox (Botulinum Toxin Type A) - Adverse Event Reports - Hospitalization - Muscular Weakness

 



Index of reports > Cases resulting in hospitalization (57) > Cases with Muscular Weakness (5)

Below is the selection of adverse event reports related to Botox (Botulinum Toxin Type A) that includes cases resulting in hospitalization where reactions include muscular weakness.

Adverse event in receiving Botox (Botulinum Toxin Type A)

Reported by a physician from United States on 2007-10-24

Patient:

Adverse reactions / side effects: Abdominal Pain, Oral Intake Reduced, Weight Decreased, Dysphagia, Pneumonia Aspiration, Incorrect Dose Administered, Muscular Weakness, Asthenia

Adverse event resulted in: hospitalization

Suspect drug(s):
Botox
    Dosage: 1370 units, single
    Indication: Cerebral Palsy
    Start date: 2007-09-18
    End date: 2007-09-18

Botox
    Indication: Muscle Spasticity



Adverse event in male receiving Botox (Botulinum Toxin Type A)

Reported by a consumer/non-health professional from Norway on 2007-10-05

Patient: male

Adverse reactions / side effects: Dysphagia, Muscular Weakness

Adverse event resulted in: hospitalization

Suspect drug(s):
Botox (Botulinum Toxin Type A)

Other drugs received by patient: Enalapril Maleate; Enanton Depot SET; Allopur; Hydrochlorothiazide



Adverse event in 2 year old female receiving Botox (Botulinum Toxin Type A)

Reported by a consumer/non-health professional from United States on 2007-06-02

Patient: 2 year old female, weighing 14.0 kg (30.8 pounds)

Adverse reactions / side effects: Dysphagia, Gastroenteritis Rotavirus, Muscular Weakness, Eyelid Ptosis, Botulism

Adverse event resulted in: hospitalization

Suspect drug(s):
Botox
    Dosage: 160 units, single
    Indication: Quadriparesis
    Start date: 2007-05-08
    End date: 2007-05-08

Botox

Botox

Other drugs received by patient: Keppra



Adverse event in 2 year old female receiving Botox (Botulinum Toxin Type A)

Reported by a consumer/non-health professional from United States on 2007-05-24

Patient: 2 year old female, weighing 14.0 kg (30.8 pounds)

Adverse reactions / side effects: Dysphagia, Muscular Weakness, Eyelid Ptosis, Botulism

Adverse event resulted in: hospitalization

Suspect drug(s):
Botox
    Dosage: 160 units, single
    Indication: Quadriparesis
    Start date: 2007-05-08
    End date: 2007-05-08

Botox

Botox



Adverse event in 40 year old female receiving Botox (Botulinum Toxin Type A)

Reported by a physician from South Africa on 2007-02-20

Patient: 40 year old female, weighing 65.0 kg (143.0 pounds)

Adverse reactions / side effects: Back Pain, Guillain-Barre Syndrome, Nausea, Hypotension, Muscular Weakness, Organ Failure, Brain Oedema, Dizziness, Pulmonary Oedema, Cytomegalovirus Infection, Respiratory Arrest, Ventricular Fibrillation, Cardiac Arrest, Muscle Spasms, Lung Injury

Adverse event resulted in: death, life threatening event, hospitalization

Suspect drug(s):
Botox
    Dosage: 22 units, single
    Indication: Skin Wrinkling
    Start date: 2006-07-27
    End date: 2006-07-27

Botox
    Dosage: 22 units, single
    Start date: 2006-10-25
    End date: 2006-10-25

Other drugs received by patient: Natrilix / 00340101 /; Diane

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009